Fig. 8

Analysis of the Therapeutic Targeting Potential of WDR54 in HNSCC cell FaDu. (A) mRNA expression level of WDR54 in WDR54-knockdown FaDu cell. (B) Cell proliferation was analyzed in WDR54-knockdown FaDu cell. (B–C) Analysis of cell viability of Cisplatin (B) and 5-Fluorouracil (C) in HNSCC cell FaDu with downregulated WDR54.^***p < 0.001.